The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.
about
Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesisImpact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.Principles of cancer screening: lessons from history and study design issues.Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.New serum biomarkers for prostate cancer diagnosis.Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks).Health perceptions in patients who undergo screening and workup for prostate cancerRisk perception and psychological morbidity in men at elevated risk for prostate cancerBeyond PSA: the next generation of prostate cancer biomarkers.The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?New concepts concerning prostate cancer screening.The psychological impact of prostate biopsy: prevalence and predictors of procedure-related distress.A systematic review of the psychological impact of false-positive colorectal cancer screening: What is the role of the general practitioner?Morbidity and psychological impact of prostate biopsy: the future calls for a change.The psychological impact of anal cancer screening on HIV-infected men.Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.False-positive screening results in the Finnish prostate cancer screening trial.Experiences of Uncertainty in Men With an Elevated PSA.Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.The risk experience: the social effects of health screening and the emergence of a proto-illness.Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer.What predicts emotional response in men awaiting prostate biopsy?Prolaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology AssessmentPlasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer
P2860
Q33746417-CD3F08DB-AF31-4DAA-899F-8F1888A0CC49Q33834396-1A3DD940-8D04-44C8-917B-CD24A66087B8Q34065705-BDB27CEC-5079-425D-994A-2A2D883549E9Q34680813-A3A398C3-FCF5-4E98-ACD1-676C22E8980BQ34939111-F6E36262-5C97-47D5-92FC-7CF24CEC151DQ35605735-ABA8C17B-0507-4F1C-981C-A966A809B0FDQ35792722-4628D3D7-4946-46EC-8173-B3F9D4C1F228Q36394622-ECE7CC5A-5966-4A2B-BDC9-FA4DF195B6C9Q37238101-66931460-856E-4E20-8688-C1E97DEC6A56Q37260341-41B6CB4E-84D9-4A54-BC90-C7D9E1C7FF3AQ38220183-93E72883-A334-430C-8C46-E39727DAA7E3Q38647436-052760E4-0D52-4020-A439-8B0960BA3096Q38792329-60F7A280-914A-4243-8C39-4D772B97C5A1Q39213491-F76E3053-F3F1-4EFD-83F4-7C9E0BD3D6C4Q39658301-61292786-7502-47B1-856F-7021382308FDQ40118979-BC6AB2D3-5902-4555-9657-CA4FDAA2DA03Q40201035-843BC960-F3DC-45CB-A3FD-3FEB71477041Q42914714-25DA47A6-B267-4907-8E6A-CB202D5E4007Q47104037-15291CF3-B022-42F1-8E82-68261AD055A5Q47392438-C36A4657-1B9B-47A2-BEC0-8FF1FFE13FE5Q48084604-E19B3481-0552-4B9F-8A8D-CDF359373ABDQ52351127-0834F9DE-4916-4811-B4DB-B34547771EB3Q55058500-531710F8-14D6-4C4B-8E85-DBA9069870C7Q57117462-968B3AFB-82D9-4AA9-9FB2-7E1DEECF7897Q58760499-2361B99E-FF95-41AE-9AB9-504F0E9A8036
P2860
The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The impact of a suspicious pro ...... al, and medical care outcomes.
@ast
The impact of a suspicious pro ...... al, and medical care outcomes.
@en
type
label
The impact of a suspicious pro ...... al, and medical care outcomes.
@ast
The impact of a suspicious pro ...... al, and medical care outcomes.
@en
prefLabel
The impact of a suspicious pro ...... al, and medical care outcomes.
@ast
The impact of a suspicious pro ...... al, and medical care outcomes.
@en
P2093
P2860
P1476
The impact of a suspicious pro ...... al, and medical care outcomes.
@en
P2093
Alison Hauser
Beth Walker-Corkery
David W Bates
Floyd J Fowler
Jean-Francois Caubet
Jeong Min Lee
Mary McNaughton-Collins
Michael J Barry
P2860
P304
P356
10.1111/J.1525-1497.2006.00464.X
P577
2006-07-01T00:00:00Z
P5875
P6179
1000022250